Ethical considerations when prescribing biologics in dermatology

Frank A Santoro; Marti J Rothe; Bruce E Strober

doi:10.1016/j.clindermatol.2011.06.018

Ethical considerations when prescribing biologics in dermatology

Clin Dermatol. 2012 Sep-Oct;30(5):492-5. doi: 10.1016/j.clindermatol.2011.06.018.

Authors

Frank A Santoro¹, Marti J Rothe, Bruce E Strober

Affiliation

¹ Department of Dermatology, University of Connecticut Health Center, 21 South Road, Farmington, CT 06030-6231, USA.

PMID: 22902219
DOI: 10.1016/j.clindermatol.2011.06.018

Abstract

There are no formal publications describing and discussing the various ethical dilemmas encountered when treating dermatologic disease with biologic therapy. Multiple issues such as safety, efficacy, drug accessibility, and cost need to be considered when prescribing biologics. This contribution uses a case-based approach to evaluate the ethical principles involved with biologic therapy.

Publication types

Case Reports

MeSH terms

Adult
Beneficence
Bioethical Issues*
Biological Products / therapeutic use*
Dermatology / ethics
Humans
Male
Psoriasis / drug therapy*
Pyoderma Gangrenosum / drug therapy*

Substances

Biological Products